News With Merck circling, SpringWorks gets new drug approval Merck KGaA is talking to SpringWorks about a takeover, and FDA approval for a neurofibromatosis drug could have sweetened any potential deal.
News Storybook can help kids understand rare kidney disease An e-Book aimed at children with rare kidney disease aHUS can help them understand the condition, deal with emotions, and find support, says Alexion.
News Pressure relieved on AZ as details of Chinese probe emerge AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.
News Report says AZ's UK plant decision is not just about funding It's been reported that the UK government made an offer of £78 million in funding for AstraZeneca's abandoned £450 million vaccine facility in Speke.
News Boost to Enhertu's prospects as FDA clears Roche diagnostic Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.
News AstraZeneca abandons plan for £450m vaccine plant in UK In a shock move, AstraZeneca has ditched its plan to invest £450m in a new vaccine manufacturing plant in the UK.
News Bavarian Nordic chikungunya vaccine gets FDA okay There are now two vaccines to protect against chikungunya approved for use in the US, after Bavarian Nordic gets the green light for Vimkunya.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl